EDITOR’S PAGE Greatest opportunities for growth in nuclear cardiology Vasken Dilsizian, MD, MASNC Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD Received May 17, 2017; accepted May 17, 2017 doi:10.1007/s12350-017-0933-9 The indispensable factor of sustaining any ﬁeld of deposition have important clinical, therapeutic, and 99m science or intellectual endeavor is the inﬂux of new prognostic implications. Tc-pyrophosphate imaging ideas and solutions to previously unsolved, but in prin- provides the opportunity to diagnose cardiac amyloido- ciple solvable problems. Over the last four decades, sis, evaluate cardiac amyloid load quantitatively, myocardial perfusion imaging has been the dominant differentiate light-chain amyloidosis from transthyretin- procedure in nuclear cardiology. A number of clinical related cardiac amyloidosis, monitor disease progres- trials have demonstrated the diagnostic and prognostic sion, and assess response to treatment. accuracy of gated myocardial perfusion studies with Targeting speciﬁc biological or chemical pathways SPECT or PET, and its relevance for patient manage- to assess normal and abnormal cellular function in vivo 1–3 ment. However, it has become increasingly apparent is the basis of molecular imaging. For example, that in the hands of the specialists, nuclear cardiology molecular imaging allows direct visualization and has grown progressively
Journal of Nuclear Cardiology – Springer Journals
Published: May 30, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera